Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial
Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd..
OBJECTIVE: To assess the effectiveness of an antispasmodic drug, hyoscine-N-butylbromide, in reducing pain during hysterosalpingo-contrast sonography (HyCoSy).
METHODS: Eight hundred and sixteen patients undergoing HyCoSy were randomized to receive 10 mg hyoscine-N-butylbromide (n = 408) or placebo (n = 408) per os, 30 min before the procedure, in a double-blind randomized controlled trial. Immediately after the procedure, the patient was asked to describe any pain experienced in comparison with pain usually suffered during the menstrual cycle, and the operator assigned a pain score between 0 and 4 as follows: 0 (no reaction or discomfort), 1 (slight pain, less than menstrual pain), 2 (moderate pain, exceeding menstrual cramps but no vasovagal reaction), 3 (vasovagal reaction or pain requiring observation in a hospital) and 4 (vasovagal reaction or pain requiring resuscitation). The primary aim was to estimate the difference in pain score, considered as a categorical value, between the active arm of the trial and the control group. The secondary aim was to evaluate if pain is related to tubal patency.
RESULTS: There was no difference in pain score between the hyoscine-N-butylbromide group and the placebo group (P = 0.807). There was a negative correlation between pain and tubal patency, regardless of treatment group (P < 0.0001).
CONCLUSIONS: Administration of 10 mg antispasmodic drug hyoscine-N-butylbromide does not reduce pain in patients undergoing HyCoSy.
| Errataetall: |
CommentIn: Ultrasound Obstet Gynecol. 2012 Mar;39(3):247-51. - PMID 22535627 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
|---|---|
| Enthalten in: |
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology - 39(2012), 3 vom: 01. März, Seite 260-5 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Moro, F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Contrast Media |
|---|
| Anmerkungen: |
Date Completed 08.08.2012 Date Revised 09.04.2022 published: Print CommentIn: Ultrasound Obstet Gynecol. 2012 Mar;39(3):247-51. - PMID 22535627 Citation Status MEDLINE |
|---|
| doi: |
10.1002/uog.11089 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM214355519 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM214355519 | ||
| 003 | DE-627 | ||
| 005 | 20231224023421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/uog.11089 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0714.xml |
| 035 | |a (DE-627)NLM214355519 | ||
| 035 | |a (NLM)22223598 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Moro, F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.08.2012 | ||
| 500 | |a Date Revised 09.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Ultrasound Obstet Gynecol. 2012 Mar;39(3):247-51. - PMID 22535627 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd. | ||
| 520 | |a OBJECTIVE: To assess the effectiveness of an antispasmodic drug, hyoscine-N-butylbromide, in reducing pain during hysterosalpingo-contrast sonography (HyCoSy) | ||
| 520 | |a METHODS: Eight hundred and sixteen patients undergoing HyCoSy were randomized to receive 10 mg hyoscine-N-butylbromide (n = 408) or placebo (n = 408) per os, 30 min before the procedure, in a double-blind randomized controlled trial. Immediately after the procedure, the patient was asked to describe any pain experienced in comparison with pain usually suffered during the menstrual cycle, and the operator assigned a pain score between 0 and 4 as follows: 0 (no reaction or discomfort), 1 (slight pain, less than menstrual pain), 2 (moderate pain, exceeding menstrual cramps but no vasovagal reaction), 3 (vasovagal reaction or pain requiring observation in a hospital) and 4 (vasovagal reaction or pain requiring resuscitation). The primary aim was to estimate the difference in pain score, considered as a categorical value, between the active arm of the trial and the control group. The secondary aim was to evaluate if pain is related to tubal patency | ||
| 520 | |a RESULTS: There was no difference in pain score between the hyoscine-N-butylbromide group and the placebo group (P = 0.807). There was a negative correlation between pain and tubal patency, regardless of treatment group (P < 0.0001) | ||
| 520 | |a CONCLUSIONS: Administration of 10 mg antispasmodic drug hyoscine-N-butylbromide does not reduce pain in patients undergoing HyCoSy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 7 | |a Contrast Media |2 NLM | |
| 650 | 7 | |a Parasympatholytics |2 NLM | |
| 700 | 1 | |a Selvaggi, L |e verfasserin |4 aut | |
| 700 | 1 | |a Sagnella, F |e verfasserin |4 aut | |
| 700 | 1 | |a Morciano, A |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez, D |e verfasserin |4 aut | |
| 700 | 1 | |a Gangale, M F |e verfasserin |4 aut | |
| 700 | 1 | |a Ciardulli, A |e verfasserin |4 aut | |
| 700 | 1 | |a Palla, C |e verfasserin |4 aut | |
| 700 | 1 | |a Uras, M L |e verfasserin |4 aut | |
| 700 | 1 | |a De Feo, E |e verfasserin |4 aut | |
| 700 | 1 | |a Boccia, S |e verfasserin |4 aut | |
| 700 | 1 | |a Tropea, A |e verfasserin |4 aut | |
| 700 | 1 | |a Lanzone, A |e verfasserin |4 aut | |
| 700 | 1 | |a Apa, R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology |d 1991 |g 39(2012), 3 vom: 01. März, Seite 260-5 |w (DE-627)NLM075077388 |x 1469-0705 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2012 |g number:3 |g day:01 |g month:03 |g pages:260-5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/uog.11089 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2012 |e 3 |b 01 |c 03 |h 260-5 | ||